139 related articles for article (PubMed ID: 6691888)
1. Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability.
Heazelwood VJ; Galligan JP; Cannell GR; Bochner F; Mortimer RH
Br J Clin Pharmacol; 1984 Jan; 17(1):55-9. PubMed ID: 6691888
[TBL] [Abstract][Full Text] [Related]
2. Comparison of absorption of cortisone acetate and hydrocortisone hemisuccinate.
Fariss BL; Hane S; Shinsako J; Forsham PH
J Clin Endocrinol Metab; 1978 Nov; 47(5):1137-40. PubMed ID: 233690
[TBL] [Abstract][Full Text] [Related]
3. Plasma cortisol concentrations following cortisone infusion in dogs before and after treatment with cortisone acetate.
Church DB; Emslie DR; Watson AD
Aust Vet J; 1999 Oct; 77(10):671-3. PubMed ID: 10590797
[TBL] [Abstract][Full Text] [Related]
4. Stable isotope methodology for kinetic studies of interconversion of cortisol and cortisone in a human subject.
Kasuya Y; Ishimaru H; Shibasaki H; Furuta T
Steroids; 1998 Mar; 63(3):122-9. PubMed ID: 9558711
[TBL] [Abstract][Full Text] [Related]
5. A possible defect in the inter-conversion between cortisone and cortisol in prepubertal patients with congenital adrenal hyperplasia receiving cortisone acetate therapy.
Whorwood CB; Warne GL
J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):461-70. PubMed ID: 1911435
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a signle oral administration of cortisone acetate to human subjects.
Colburn WA; DiSanto AR; Stubbs SS; Monovich RE; DeSante KA
J Clin Pharmacol; 1980 Jul; 20(7):428-36. PubMed ID: 7430411
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation.
Kehlet H; Binder C; Blichert-Toft M
Clin Endocrinol (Oxf); 1976 Jan; 5(1):37-41. PubMed ID: 1248157
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Charmandari E; Johnston A; Brook CG; Hindmarsh PC
J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
[TBL] [Abstract][Full Text] [Related]
9. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
Løvås K; Thorsen TE; Husebye ES
J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
[TBL] [Abstract][Full Text] [Related]
10. Serum cortisol appearance-disappearance in adrenal insufficiency after oral cortisone acetate.
Barbato AL; Landau RL
Acta Endocrinol (Copenh); 1977 Mar; 84(3):600-4. PubMed ID: 576533
[TBL] [Abstract][Full Text] [Related]
11. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
[TBL] [Abstract][Full Text] [Related]
12. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
[TBL] [Abstract][Full Text] [Related]
13. Suggested in vivo irreversible metabolism of labeled cortisol during distribution: effects on kinetic measurements and role of modes and sites of administration.
Gold NI; Grigler JF
J Clin Endocrinol Metab; 1972 Jun; 34(6):1025-38. PubMed ID: 4553515
[No Abstract] [Full Text] [Related]
14. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific dysregulation of cortisol metabolism in human obesity.
Rask E; Olsson T; Söderberg S; Andrew R; Livingstone DE; Johnson O; Walker BR
J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
[TBL] [Abstract][Full Text] [Related]
16. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
[TBL] [Abstract][Full Text] [Related]
17. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone.
Meulenberg PM; Ross HA; Swinkels LM; Benraad TJ
Clin Chim Acta; 1987 Jun; 165(2-3):379-85. PubMed ID: 3652459
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of cortisone and cortisone/cortisol ratio in evaluating children with adrenal diseases.
Nomura S; Fujitaka M; Jinno K; Sakura N; Ueda K
Clin Chim Acta; 1996 Dec; 256(1):1-11. PubMed ID: 8960783
[TBL] [Abstract][Full Text] [Related]
20. Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state.
Aanderud S; Myking OL
Acta Med Scand; 1981; 210(3):157-61. PubMed ID: 7293833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
